Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 8, Pages 3038-3043Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1400709111
Keywords
transcriptional profiling; differentiation; beta cells; MARIS
Categories
Funding
- Sternlicht Director's Fund Fellowship
- Harvard Stem Cell Institute (HSCI) Training Grant
- Helmsley Charitable Trust
- Harvard Stem Cell Institute
- National Institutes of Health [2U01DK07247307, RL1DK081184, 1U01HL10040804]
Ask authors/readers for more resources
Human pluripotent stem cells (hPSCs) have the potential to generate any human cell type, and one widely recognized goal is to make pancreatic beta cells. To this end, comparisons between differentiated cell types produced in vitro and their in vivo counterparts are essential to validate hPSC-derived cells. Genome-wide transcriptional analysis of sorted insulin-expressing (INS+) cells derived from three independent hPSC lines, human fetal pancreata, and adult human islets points to two major conclusions: (i) Different hPSC lines produce highly similar INS+ cells and (ii) hPSC-derived INS+ (hPSC-INS+) cells more closely resemble human fetal beta cells than adult beta cells. This study provides a direct comparison of transcriptional programs between pure hPSC-INS+ cells and true beta cells and provides a catalog of genes whose manipulation may convert hPSC-INS+ cells into functional beta cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available